Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 4.5 Specimen Common Stock Certificate of Blade Biotherapeutics, Inc.
- 10.26 Common Stock Purchase Agreement
- 10.27 Registration Rights Agreement
- 23.1 Consent of Marcum LLP
- 23.2 Consent of Ernst and Young LLP, Independent Registered Accounting Firm for Blade Therapeutics, Inc.
- 99.9 Consent of Michael Shleifer to Be Named As a Director
- Download Excel data file
- View Excel data file
Associated filings
- 17 Jun 22 RW Registration withdrawal request
- 23 May 22 424B3 Prospectus supplement
- 10 May 22 EFFECT Notice of effectiveness
- 9 May 22 424B3 Prospectus supplement
- 9 May 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
3 May 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Apr 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 1 Apr 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Mar 22 S-4 Registration of securities issued in business combination transactions
BIOT similar filings
Filing view
External links
Exhibit 99.9
Consent to be Named as a Director
In connection with the filing by Biotech Acquisition Company of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto as a member of the board of directors of Biotech Acquisition Company following the consummation of the business combination, which will be renamed Blade Biotherapeutics, Inc. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
Dated: April 20, 2022
By: | /s/ Michael Schleifer | |
Michael Schleifer |